Be a Smart Investor
Tuesday, October 10, 2017
Express Scripts' $3.6 billion deal is 'a necessity' to fend off competition
Express Scripts said the acquisition of eviCore will allow it to expand beyond its prescription drug benefit services.
from Mergers and Acquisitions http://ift.tt/2yaxd2B
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment